To assess the validity of White's classification, including the role of chronic hypertension, in a contemporary diabetic population.
OBJECTIVE:
To assess the validity of White's classification, including the role of chronic hypertension, in a contemporary diabetic population.
METHODS:
We performed a retrospective cohort study of all singleton pregnancies with pre-existing diabetes mellitus from 2008 to 2013. Adverse outcomes were compared across classes B, C, D, and vascular disease (R, F, H) and further stratified by the presence or absence of chronic hypertension. Outcomes examined were a composite perinatal outcome (stillbirth, neonatal death, shoulder dystocia, birth injury, seizures, requiring chest compressions or intubation at delivery, blood pressure support), small for gestational age (SGA), large for gestational age (LGA), macrosomia, shoulder dystocia, preterm delivery at less than 37 weeks of gestation, preeclampsia, and cesarean delivery.
RESULTS:
Of the 475 patients, the 1980 White's classification was significantly associated with SGA, LGA, macrosomia, preterm delivery, preeclampsia, and cesarean delivery (P#.01). Within each White's class based on age or time since diagnosis alone, hypertension was significantly associated with a higher incidence of preeclampsia in class B (16% without hypertension compared with 32% with hypertension, P,.01) and C (22% compared with 40%, P5.04), SGA in C (4.7% compared with 21%, P,.01), preterm delivery in B (25% compared with 46%, P,.01) and C (35% compared with 58%, P5.01), and the composite neonatal outcome in B (7.9% compared with 17%, P5.03). The incidence of adverse outcomes in classes B and C with hypertension resembles the incidence of adverse outcomes in those with diabetes one class higher.
CONCLUSION:
The 1980 White's classification system, taking into consideration the presence of chronic hypertension, remains a useful system for counseling pregestational diabetic women regarding adverse pregnancy outcomes. 
LEVEL OF EVIDENCE: II

W
hite's classification was developed by Priscilla White 1 in 1949 to estimate the risks of "perinatal wastage" in pregnancies complicated by diabetes. She concluded that pregnancy complications could be predicted by maternal factors such as disease duration, age of onset, and the presence or absence of vascular diseases such as "transitory" hypertension, retinopathy, nephropathy, or heart disease. In the 1980 revision, the classification system was revised to upstage those with chronic hypertension to class D regardless of their age at diagnosis or duration of disease (Box 1). 2 In stark contrast to today's diabetic population, White's 1 classification was based largely on women with type 1 diabetes mellitus. The increasing rates of childhood obesity and the overall increase in obesity in the population have resulted in more women of reproductive age with type 2 diabetes mellitus. A recent study over an 8-year period revealed a 21.1% and 30.5% increase in the prevalence of type 1 diabetes mellitus and type 2 diabetes mellitus, respectively, in children. [3] [4] [5] [6] With changes in the demographics and type of diabetes in reproductive-aged women, it is useful to reassess the utility of White's classification. 7 The practice of upstaging the class of diabetes to category D in the presence of hypertension has not been widely accepted. 8 This may be the result of the widespread coexisting diagnosis of hypertension in type 2 diabetes mellitus such that practitioners do not consider hypertension a complication of diabetes.
Owing to changes in both the obstetric population and alterations in the uses of White's classification system, we aimed to evaluate the validity of White's classification in predicting adverse pregnancy outcomes in a modern cohort and to assess the effects of hypertension on perinatal outcomes within each White classification.
MATERIALS AND METHODS
This was a retrospective cohort study of all singleton pregnancies delivered from 2008 to 2013 at the University of Alabama at Birmingham with a diagnosis of pregestational diabetes. Institutional review board approval was obtained.
Patients were identified from the obstetric automated record system 9 and a diagnosis of pregestational diabetes was confirmed on review of medical records. Only patients who reported a history of diabetes before pregnancy were considered to have pregestational diabetes; patients diagnosed by glucose tolerance testing during pregnancy were considered to have gestational diabetes and excluded from this analysis regardless of gestational age at diagnosis. Trained personnel reviewed electronic medical records to abstract pertinent information using standardized data collection forms. Maternal data included age, ethnicity, insurance status, prepregnancy body mass index (calculated as weight (kg)/ [height (m)] 2 ), comorbid conditions, age of diabetes diagnosis, type of diabetes, use of prepregnancy hypoglycemic medications, baseline laboratory values (hemoglobin A 1c , urine protein and creatinine, 24-hour urine), obstetric history, delivery details, selected maternal complications, and perinatal outcomes. Patients were excluded for late prenatal care (first ultrasonography after 26 weeks of gestation), any fetal anomaly, and major maternal comorbidities unrelated to diabetes other than chronic hypertension (eg, systemic lupus erythematosus, human immunodeficiency virus, and hepatitis). For this analysis, patients were excluded if information related to their diabetes diagnosis (age or year of diagnosis) was not available. Maternal-Fetal Medicine specialists supervised the care of all patients. As per institutional protocol, diabetic medications (oral hypoglycemic or insulin) were adjusted to maintain goal blood sugars of less than 95 mg/dL fasting and less than 120 mg/dL 2-hour postprandial. 3 Ultrasonograms for fluid and growth were routinely performed every 4 weeks beginning at 28 weeks of gestation, and antenatal testing (once or twice weekly) was started at 32-34 weeks of gestation. Delivery was scheduled for between 39 and 40 weeks of gestation or earlier if evidence of poor diabetic control or positive fetal lung maturity testing.
Patients were classified according to the 1980-revised White's classification to create Tables 1-3 . Each class was determined by maternal age at diagnosis and disease duration, additionally upstaging class B and C patients with chronic hypertension to class D. Women were considered to have proliferative retinopathy if documented as having "proliferative retinopathy" and background retinopathy if documented as "background" or "benign." In cases in which a woman was documented to have unclassified "retinopathy," we assumed proliferative retinopathy because documentation otherwise would have most likely not occurred. Classes F, R, RF, and H were combined to create a "vascular" class resulting from the small number of patients representing each of these groups.
To evaluate the predictive value of the type of diabetes and vascular complications on pregnancy outcomes, we stratified each diabetes type by those with and without vascular complications. Women with any retinopathy, nephropathy, heart disease, or a combination were considered to have a vascular complication. Unauthorized reproduction of this article is prohibited.
To assess the effects of chronic hypertension on pregnancy outcomes, we also classified women according to only maternal age at diagnosis and disease duration classifying those with end-organ damage (retinopathy, nephropathy, heart disease) in the vascular category only. The effect of stratifying each class by the presence or absence of chronic hypertension was then analyzed, as shown in Figure 1 .
The primary perinatal outcome was a composite of stillbirth, neonatal death, shoulder dystocia, birth injury (brachial plexus injury, fracture), neonatal seizures, blood pressure support, or a high level of resuscitation in the delivery room (cardiopulmonary resuscitation or intubation). Stillbirth was also considered separately as a primary outcome. Secondary perinatal outcomes considered were shoulder dystocia, small for gestational age (SGA, less than the 10th percentile), 10 large for gestational age (LGA, greater than the 90th percentile), 10 macrosomia (birth weight greater than 4,000 g), and preterm delivery (delivery at less than 37 weeks of gestation). Outcomes that were a direct marker of an adverse outcome were considered a primary outcome. The secondary outcomes were surrogate markers chosen based on outcomes that were associated but did not always result in a poor outcome.
Maternal outcomes considered included preeclampsia and cesarean delivery. Cesarean delivery was considered as both any cesarean delivery (primary or repeat) and primary cesarean delivery only. Preeclampsia was
Maternal characteristics were compared with descriptive and univariable statistics using analysis of variance for continuous variables and x 2 tests for categorical variables as appropriate. Rates of maternal and neonatal outcomes across White's classifications were compared using a x 2 test for trend. All analyses were completed using Stata SE 13. A P value ,.05 was chosen to represent statistical significance.
RESULTS
Of the 597 patients identified with a diagnosis of pregestational diabetes, 475 were included in the study (62 women were excluded owing to a major concurrent maternal medical problem, 51 had an infant with a congenital malformation, and nine had late entry to prenatal care) (Fig. 2) . Of the 475 patients, classified by the 1980 White's revision categorizing women with chronic hypertension as D in Tables 1-3, 128 (27%) were classified as B, 86 (18%) as C, 208 (44%) as D, and 53 (11%) as vascular (classes F, R, RF, and H). The Unauthorized reproduction of this article is prohibited.
proportion of African American race, type 1 diabetes mellitus, nulliparous patients, and patients on prepregnancy diabetic medications increased across each class ( Table 1 ). The mean body mass index in each class was 3366.4 in B, 3269 in C, 37611 in D, and 3468 in the vascular class. Type of insurance, tobacco use, prior preterm delivery, and prior cesarean delivery did not vary by White's classification. The increasing risks of composite perinatal outcome and stillbirth in the class D and vascular compared with B and C were not statistically significant (P5.07 and P5.08, respectively) ( Table 2 ). Rates of SGA increased across the advancing White's classification groups (B to vascular, P,.01), whereas the inverse was true for LGA (P,.01) and macrosomia (P,.01), which occurred more frequently in class B. Although the incidence of fetal overgrowth decreased from the B to vascular classes, the decreased incidence of shoulder dystocia did not reach statistical significance. A significant effect of advancing White's class on preterm delivery (P,.01) was observed. Table 3 depicts maternal outcomes by White's classification. A trend (P#.01) of increasing rates of preeclampsia and any cesarean delivery (primary and repeat) occurred with increasing White's class (B to vascular). A statistically significant trend (P#.02) of increasing SGA, preterm delivery, and preeclampsia was observed in those with a vascular complication, which occurred more frequently in type 2 diabetes mellitus (Table 4 ). Conversely, rates of LGA (P5.02) and macrosomia (P5.04) increased among those without a vascular complication, occurring more commonly in type 1 diabetes mellitus. Additionally, the presence or absence of vascular disease appeared to be more predictive of adverse outcomes than the type of diabetes.
To evaluate the effect of chronic hypertension on White's classification, patients were classified using the 1949 White's classification version by maternal age at diagnosis and disease duration, and then each class was further stratified by the presence or absence of chronic hypertension. Within each class, women with hypertension had a higher incidence of the outcomes of interest (adverse composite perinatal outcome, SGA, preterm delivery, and preeclampsia) than women in the same class without hypertension (Fig. 2 ). These differences were statistically significant for White's classes B and C for both preeclampsia (B-16% without hypertension compared with 32% with hypertension and C-22% compared with 40%) and preterm delivery (B-25% compared with 46% and C-35% compared with 58%), whereas outcomes were similar in class D for women with and without chronic hypertension. A significant difference in the rate of adverse neonatal composite outcomes emerged in White's class B only (7.9% compared with 17%), and SGA was statistically significant in only class C (4.7% compared with 21%). The effect of chronic hypertension was null in class D.
DISCUSSION
In this contemporary cohort, using the 1980 revision of White's classification system, which utilizes chronic hypertension to reclassify women with classes B and C as class D, assigned class was significantly associated with adverse perinatal outcomes including fetal growth disorders, preeclampsia, and cesarean delivery. Interestingly, the incidence of LGA and macrosomia decreased as the class increased toward the vascular categories, whereas the incidence of SGA increased. Although probably underpowered to show significance, an increasing incidence in both outcomes of the composite perinatal outcome and stillbirth as well as a decreasing incidence of shoulder dystocia was observed across each White's class. Furthermore, the presence of vascular disease, being more distinctive than diabetes type, was significantly associated with SGA, preterm delivery, and preeclampsia. Conversely, the incidence of LGA and macrosomia was decreased in those with vascular disease. Our findings revealed that within each class of diabetes defined based on maternal age at diagnosis and disease duration, hypertension is associated with a significantly increased incidence of SGA, preeclampsia, preterm delivery, and composite perinatal outcome. Although White's classification was associated with adverse outcomes, the presence of hypertension appeared to have a significant effect on the occurrence of adverse outcomes, validating the 1980 revision.
Multiple studies have evaluated the validity of White's classification, including Pederson et al, who set out to improve the methods for identifying diabetic pregnancies at risk for adverse outcomes. 8, 11, 12 They created a new system by identifying four "prognostically bad signs of pregnancy," which included Unauthorized reproduction of this article is prohibited.
clinical pyelonephritis, precoma and severe acidosis, toxemia (ie, preeclampsia or eclampsia), and maternal neglectors (eg, late entry to prenatal care, poor social circumstances). They concluded that his classification system, when combined with White's class, improved the prediction of adverse outcomes.
11
In 1987 Diamond et al 12 examined both Pederson's prognostically bad signs of pregnancy and White's classification system. In this retrospective cohort of 199 diabetic pregnancies, they found that both White's classification and Pederson's prognostic factors were associated with perinatal death, neonatal respiratory morbidity, and birth weight. However, because this cohort was composed of women from 1977 to 1983, these findings do not necessarily apply to a contemporary diabetic cohort.
Cormier et al also examined White's classification system in a contemporary obstetric cohort of 114 gestational and 82 pregestational diabetic women. In this study, women with hypertension were not assigned a D class. They concluded that the presence of vascular disease (including hypertension) was more predictive of adverse outcome than White's classification based on disease duration and maternal age of onset alone. 8 This is consistent with our findings that chronic hypertension results in worsened outcomes; however, they did not examine the results according to the 1980 White's classification revision with all women with chronic hypertension classified as D.
One of our study's strengths is in the detailed clinical information collected by clinicians trained in chart abstraction. Confirmation of both the exposure (pregestational diabetes) and the perinatal outcome minimized misclassification bias. Additionally, we had a relatively large sample size of pregestational diabetic women compared with prior studies, enabling us to stratify by White's classification and examine uncommon outcomes.
The main limitation of our study is that, although we had a significant number of women with diabetes class suggestive of vascular disease (n553), we had relatively few of each subcategory (R, F, H). Consequently, although we were able to examine the presence of any vascular disease (proliferative retinopathy, nephropathy, or heart disease) on perinatal outcomes, we were unable to explore the contribution of each specific subcategory to adverse perinatal outcomes. Also, the type of retinopathy was often not specified in our obstetric documentation diminishing our ability to distinguish benign from proliferative retinopathy. Additionally, because not all women underwent ophthalmologic examination during pregnancy, this may have led to underestimation of the association between the vascular class and adverse perinatal outcomes. Of note, because our goal was to examine White's classification by outcomes, we did not think it was necessary to adjust the results by the baseline characteristics for this specific analysis.
Our study confirms that hypertension is a major prognostic factor and has a significant effect on adverse outcomes. This validates the 1980 revision of White's classification, which upgrades women with class B and chronic hypertension to class D. Indeed, women with chronic hypertension who would otherwise be classified as B or C had outcomes similar to women who would be classified as D. Overall, White's classification still provides simple and useful information for counseling women on pregnancy risks and prognosis based on information available either before pregnancy or at the first prenatal visit. Lastly, we believe that if White's class is used to counsel patients, those with chronic hypertension should be classified as class D.
